Voluntary Limits On Antibacterial Discharges Increase As Fear Of Resistance Grows
Executive Summary
Pharmaceutical companies are ratcheting up voluntary efforts to control discharges of antimicrobials from their plants and those of their active pharmaceutical ingredient suppliers so they won’t contribute to antimicrobial resistance. But will it be enough to fend off regulation in countries like India?